Criteria | Present %(n) |
Approved therapeutic use | 87.88 (n=29) |
Side effects and major ADRs | 33.33 (n=11) |
Precautions, Contra‐indications, Warnings | 36.36 (n=12) |
Major interactions | 9.09 (n=3) |
Management in case of over dose/toxicity | 12.12 (n=4) |
Use in pregnancy and lactation | 12.12 (n=4) |